Form 4 Tracker
Mark E. Sims

Chief Commercial Officer · 1 filing · Latest: Jul 6, 2026

Candel Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing